132 filings
Page 2 of 7
S-8
eps5n1
9 May 24
Registration of securities for employees
7:46pm
8-K
urbh1iqvfpqu
9 May 24
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
4:04pm
ARS
om0e051 xoxt7d
23 Apr 24
Annual report to shareholders
5:29pm
DEFA14A
c3a2fph1a1rh
23 Apr 24
Additional proxy soliciting materials
5:16pm
8-K
q96runta
16 Apr 24
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
8:04am
8-K
8wmuh478870
27 Feb 24
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
4:09pm
8-K
q2vg4huvozdw
7 Feb 24
Departure of Directors or Certain Officers
4:56pm
8-K
k35buk7 r1
31 Jan 24
Amendments to Articles of Incorporation or Bylaws
4:40pm
8-K
hixa6n kx
8 Jan 24
Regulation FD Disclosure
7:59am
8-K
rq59 4fhof
20 Dec 23
Regulation FD Disclosure
8:01am
8-K
f0awe3ix4 11h28nfqnq
15 Dec 23
Other Events
8:41am
424B7
s18b1h
15 Dec 23
Prospectus with selling stockholder info
8:38am
8-K
fgeur
9 Nov 23
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
8:03am
8-K
wlsiuyduzj1 2ne
2 Oct 23
Decoding Biology To Radically Improve Lives Early October 2023
7:48am
8-K
hyavp1 b2c8
5 Sep 23
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
8:01am
8-K/A
967bo
11 Aug 23
Submission of Matters to a Vote of Security Holders
4:12pm